What is the added value of actual tumor measurements (TM) in predicting overall survival (OS)? The North Central Cancer Treatment Group (NCCTG) findings

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 6520-6520 ◽  
Author(s):  
M. E. Campbell ◽  
S. J. Mandrekar ◽  
S. L. Hillman ◽  
R. M. Goldberg ◽  
A. A. Adjei ◽  
...  
Keyword(s):  
Overall Survival ◽  
Treatment Group ◽  
Cancer Treatment ◽  
Added Value ◽  
North Central ◽  
The North ◽  
Tumor Measurements

scholarly journals Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group

2008 ◽  
Vol 49 (6) ◽  
pp. 1074-1080 ◽  
Author(s):  
Thomas E. Witzig ◽  
Susan M. Geyer ◽  
Paul J. Kurtin ◽  
Joseph P. Colgan ◽  
David J. Inwards ◽  
...  
Keyword(s):  
Treatment Group ◽  
Cancer Treatment ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Salvage Chemotherapy ◽  
North Central ◽  
The North ◽  
Non Hodgkin Lymphoma

Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51

2007 ◽  
Vol 48 (7) ◽  
pp. 1290-1298 ◽  
Author(s):  
David M. Kurtz ◽  
Loren K. Tschetter ◽  
Jacob B. Allred ◽  
Susan M. Geyer ◽  
Paul J. Kurtin ◽  
...  
Keyword(s):  
Treatment Group ◽  
Cancer Treatment ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Interleukin 4 ◽  
North Central ◽  
The North ◽  
Non Hodgkin Lymphoma

scholarly journals Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group

Cancer ◽  
2008 ◽  
Vol 113 (1) ◽  
pp. 108-116 ◽  
Author(s):  
David J. Inwards ◽  
Paul A. S. Fishkin ◽  
David W. Hillman ◽  
David W. Brown ◽  
Stephen M. Ansell ◽  
...  
Keyword(s):  
Treatment Group ◽  
Cancer Treatment ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
Long Term Results ◽  
North Central ◽  
The North ◽  
Mantle Cell

A Tomato-Based, Lycopene-Containing Intervention for Androgen-Independent Prostate Cancer: Results of a Phase II Study from The North Central Cancer Treatment Group

Urology ◽  
2007 ◽  
Vol 69 (2) ◽  
pp. 289-294 ◽  
Author(s):  
Aminah Jatoi ◽  
Patrick Burch ◽  
David Hillman ◽  
Joanne M. Vanyo ◽  
Shaker Dakhil ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Treatment Group ◽  
Cancer Treatment ◽  
Phase Ii ◽  
Phase Ii Study ◽  
North Central ◽  
The North ◽  
Androgen Independent
Sign in / Sign up

Export Citation Format

Share Document